TLDR
- ARK Invest purchased 437,345 CoreWeave shares valued at $31.3 million on Monday, extending a multi-session buying streak
- Wood’s firm added CRISPR Therapeutics, Circle Internet Group, and Bullish while trimming GitLab, Reddit, Iridium, and Ibotta
- CoreWeave has declined 44% in one month but revenue is projected to surge from $5 billion to $12 billion next year
- ARK sold 646,911 GitLab shares worth $26.8 million, continuing recent selling pattern in the software stock
- The AI infrastructure provider has a $55.6 billion revenue backlog, up 271% year-over-year
Cathie Wood’s ARK Invest made waves on Monday with a $31.3 million purchase of CoreWeave shares. The firm bought 437,345 shares of the AI cloud infrastructure company. This continues a buying pattern from last week when ARK purchased 350,734 shares worth $24.27 million on Friday.
CoreWeave, Inc. Class A Common Stock, CRWV
The timing is eye-catching. CoreWeave stock has dropped 44% over the past month. ARK appears to view the decline as a buying opportunity rather than a warning sign.
CoreWeave went public in March 2025 at $40 per share. The stock soared to $187 by late June before retreating to current levels around $73.60. Despite the volatility, shares remain up 84% from the IPO price.
The company specializes in data center solutions optimized for AI workloads. It began as a crypto mining operation eight years ago. When crypto markets crashed, the founders bought discounted GPUs from failed mining companies and shifted focus to AI infrastructure.
Revenue Growth Drives Confidence
CoreWeave’s financial trajectory explains Wood’s interest. The company posted $1.9 billion in revenue last year. That figure is expected to exceed $5 billion this year.
Wall Street analysts forecast revenue will more than double again in 2026, reaching $12 billion. The company reported a $55.6 billion revenue backlog at the end of June. This backlog grew 271% compared to the previous year.
CoreWeave currently operates at a loss as it invests heavily in expansion. Analysts don’t expect profitability until 2027 at the earliest. The company also carries substantial debt despite its IPO proceeds.
Crypto and Biotech Additions
ARK Invest expanded its crypto exposure on Monday. The firm purchased 8,246 Circle Internet Group shares worth $588,000. It also bought 13,402 Bullish shares valued at $517,000.
Circle went public in 2025 at $31 per share and now trades around $72.74. The stablecoin issuer reported 66% revenue growth in its most recent quarter. Wood has purchased Circle shares for five consecutive trading days.
ARK also added 42,404 shares of CRISPR Therapeutics worth approximately $2.1 million. This continues the firm’s buildup in the gene-editing biotech company.
GitLab Selling Continues
On the selling side, ARK offloaded 646,911 GitLab shares worth $26.8 million. This marks the second straight day of GitLab sales. The firm sold 670,144 shares worth $28.49 million on Friday.
The pattern suggests ARK is systematically reducing its GitLab position. The software development platform has faced consistent selling pressure from Wood’s funds.
ARK also trimmed several other holdings. The firm sold 179,578 Iridium Communications shares worth $2.88 million. It sold 62,100 Ibotta shares valued at $1.38 million and a small 100-share position in Reddit worth about $18,000.
Robinhood Markets also saw ARK buying activity during the session. The trading platform has doubled its stock price in 2025. Its third-quarter revenue jumped 100% to $1.27 billion, driven by surging crypto and options trading volumes.


